Patents let pharmaceutical firms price new therapeutics largely free from competitive constraint. Outside the U.S., value-based pricing (VBP) ties market access and price to evidence of therapeutic benefit or…
Digital therapeutics (DTx) are increasingly established, yet their mechanisms of action (MoA) remain underexplored. This article defines and categorizes DTx MoA through a novel conceptual framework,…
Background Severe burn injuries remain a significant challenge for healthcare systems despite major advances in treatment. While specialized burn centers play a crucial role in patient care, it remains unclear…
Gesundheitsapps sind längst allgegenwärtig, vom Schrittzähler im Handy bis zur spezialisierten digitalen Therapie. In der neuen Background-Ausgabe von „Wirklich Wirtschaft“ erklärt Dr. Sabrina Schubert,…
